糖尿病合并COVID‐19患者的非胰岛素类降糖药物治疗:一项系统综述和荟萃分析
Abstract Background Patients with diabetes are more likely to suffer COVID‐19 complications. Using noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved challenging. In this study, we evaluate different noninsulin AGMs in patients with COVID‐19. Methods We searched Med...
Main Authors: | Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Journal of Diabetes |
Subjects: | |
Online Access: | https://doi.org/10.1111/1753-0407.13359 |
Similar Items
-
一线降糖药物对动脉硬化改善的影响:贝叶斯网络荟萃分析
by: Jincheng Wang, et al.
Published: (2023-08-01) -
糖尿病病程及体重减轻与糖尿病患者胰腺癌的发病年龄及远处转移相关
by: Minglei Ma, et al.
Published: (2022-04-01) -
新型冠状病毒肺炎疫情对卒中住院患者认知功能及心理状态的影响
by: 龚浠平,李轶,柴明东,余苹,赵性泉,王拥军,董可辉
Published: (2021-08-01) -
SARS‐CoV2对青少年发病的2型糖尿病的影响:新确诊与严峻性
by: Sean DeLacey, et al.
Published: (2022-08-01) -
基于ACP方法的新型冠状病毒肺炎疫情管控措施效果评估
by: 马亮, et al.
Published: (2020-03-01)